-
Product Insights
Presbyopia – Drugs In Development, 2023
Global Markets Direct’s, ‘Presbyopia - Drugs In Development, 2023’, provides an overview of the Presbyopia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Presbyopia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olvimulogene Nanivacirepvec in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olvimulogene Nanivacirepvec in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olvimulogene Nanivacirepvec in Endometrial Cancer Drug Details: Olvimulogene nanivacirepvec (GL-ONC1)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pilocarpine in Presbyopia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pilocarpine in Presbyopia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pilocarpine in Presbyopia Drug Details: Pilocarpine (MicroLine) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Pembrolizumab+Vibostolimab) in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Pembrolizumab+Vibostolimab) in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Pembrolizumab+Vibostolimab) in Follicular Lymphoma Drug Details: MK-7684A is under development for the...
-
Track & Monitor
Innovation in medical: ultrasonic nebulizers
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the medical industry’s ultrasonic nebulizers segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Company Profile
Eyenovia Inc – Company Profile
Eyenovia Inc (Eyenovia) is an ophthalmic biopharmaceutical company. It discovers and develops treatments for eye diseases. It offers an optejet dispenser, a horizontal topical delivery system to administer eyedrop medications. It works in partnership with Arctic Vision Shanghai Biotechnology Co Ltd, Bausch Health Companies Inc, and Senju Pharmaceutical Co Ltd to develop its products. The company brands include eyenovia, optejet, MAP. Eyenovia is headquartered in New York City, New York, the US.
Add to Basket -
Product Insights
Eyenovia Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Eyenovia Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Eyenovia Inc (Eyenovia) is an ophthalmic biopharmaceutical company. It discovers and develops treatments for eye diseases. It offers Optejet dispenser, a horizontal topical delivery system to administer eyedrop medications. It works in partnership with Arctic Vision Shanghai Biotechnology Co Ltd, Bausch Health Companies Inc, and Senju pharmaceutical Co Ltd to develop its products. The company brands includes eyenovia, optejet, MAP....
-
Product Insights
Presbyopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Presbyopia Pipeline Drugs Market Report Overview Presbyopia is an eye condition in which the eye slowly loses the ability to focus quickly on close objects. Presbyopia happens in people as they age. Signs and symptoms include headaches, eyestrain, difficulty reading small print, and fatigue. Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis, and eye trauma. The Presbyopia pipeline drugs market research report provides comprehensive information on the therapeutics under development for Presbyopia, complete with analysis by...
-
Product Insights
Net Present Value Model: MicroLine
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model MicroLine Drug Details Pilocarpine (MicroLine) is...
-
Product Insights
Net Present Value Model: MicroStat
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model MicroStat Drug Details Fixed dose combination...